Therefore, future studies should further evaluate synovial lymphocyte percentage in combination with established and emerging biomarkers, such as IL-6, to determine whether multimarker panels can further enhance diagnostic accuracy in PJI. Here, IL6 is linked to juvenile polyposis syndrome.